Skip links

Roctavian™ (valoctocogene roxaparvovec-rvox)

Full Name Roctavian™ (valoctocogene roxaparvovec-rvox)
Drug Roctavian
Manufacturer BioMarin Pharmaceutical Inc.
Route of Administration Intravenous
Site of Care Healthcare Facility
Approved Indication The treatment of adults with severe hemophilia A (congenital factor VIII deficiency with factor VIII activity < 1 IU/dL) without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test
Disease Hemophilia A
Therapeutic Area Hematology; Cell & Gene Therapy
Enrollment Form Link Roctavian Enrollment Form
Phone Number 800-358-0013
Fax Number 877-631-9228
Product Website